BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Prognosis
51 results:

  • 1. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
    Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR
    BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer.
    You S; Gong C; Li Y; Xie Y; Li Y; Zhao Y; Wang B
    Front Endocrinol (Lausanne); 2023; 14():1270453. PubMed ID: 37881502
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study.
    Castro-Espin C; Bonet C; Crous-Bou M; Nadal-Zaragoza N; Tjønneland A; Mellemkjær L; Hajji-Louati M; Truong T; Katzke V; Le Cornet C; Schulze MB; Jannasch F; Masala G; Sieri S; Panico S; Di Girolamo C; Skeie G; Borch KB; Olsen KS; Sánchez MJ; Amiano P; Chirlaque MD; Guevara M; Sund M; Bodén S; Gunter MJ; Gonzalez-Gil EM; Weiderpass E; Aguilera-Buenosvinos I; Tsilidis KK; Heath AK; Aune D; Dossus L; Agudo A
    BMC Med; 2023 Jun; 21(1):225. PubMed ID: 37365585
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mutational signatures for breast cancer diagnosis using artificial intelligence.
    Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
    J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
    Murakami M; Fujimori N; Nakata K; Nakamura M; Hashimoto S; Kurahara H; Nishihara K; Abe T; Hashigo S; Kugiyama N; Ozawa E; Okamoto K; Ishida Y; Okano K; Takaki R; Shimamatsu Y; Ito T; Miki M; Oza N; Yamaguchi D; Yamamoto H; Takedomi H; Kawabe K; Akashi T; Miyahara K; Ohuchida J; Ogura Y; Nakashima Y; Ueki T; Ishigami K; Umakoshi H; Ueda K; Oono T; Ogawa Y
    J Gastroenterol; 2023 Jun; 58(6):586-597. PubMed ID: 37099152
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran.
    Afzaljavan F; Vahednia E; Barati Bagherabad M; Vakili F; Moezzi A; Hosseini A; Homaei Shandiz F; Kooshyar MM; Nassiri M; Pasdar A
    BMC Med Genomics; 2023 Apr; 16(1):72. PubMed ID: 37016353
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study.
    Gunnarsdottir FB; Bendahl PO; Johansson A; Benfeitas R; Rydén L; Bergenfelz C; Larsson AM
    Breast Cancer Res; 2023 Mar; 25(1):29. PubMed ID: 36945037
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
    Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
    PeerJ; 2023; 11():e15025. PubMed ID: 36935920
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab.
    Jiang S; Geng S; Gao X; Liu T; Luo X; Wang N; Shi N; Dong M
    Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):616-625. PubMed ID: 36809922
    [No Abstract]    [Full Text] [Related]  

  • 10. Predicting hormone receptors and PAM50 subtypes of breast cancer from multi-scale lesion images of DCE-MRI with transfer learning technique.
    Ming W; Li F; Zhu Y; Bai Y; Gu W; Liu Y; Sun X; Liu X; Liu H
    Comput Biol Med; 2022 Nov; 150():106147. PubMed ID: 36201887
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Application of next-generation sequencing in detection of BRCA1/2 and homologous recombination repair pathway multi-genes germline mutation and correlation analysis].
    Chen YL; Zhuo ZL; Liu C; Xie F; Yang ZY; Liu PF; Wang S; Zhao XT
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Mar; 56(3):302-311. PubMed ID: 35381651
    [No Abstract]    [Full Text] [Related]  

  • 12. Promotion of tumorigenesis by miR-1260b-targeting casp8: Potential diagnostic and prognostic marker for breast cancer.
    Park S; Kim J; Cho Y; Ahn S; Kim G; Hwang D; Chang Y; Ha S; Choi Y; Lee MH; Han H; Kim S; Kim SI; Lee H
    Cancer Sci; 2022 Jun; 113(6):2097-2108. PubMed ID: 35325509
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer.
    Yao K; Schaafsma E; Zhang B; Cheng C
    PLoS Comput Biol; 2022 Mar; 18(3):e1009495. PubMed ID: 35263321
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Inhibitory Effect of Lentivirus-Mediated Gag-Caspase-8 on the Growth of HER-2 Overexpressing Primary Human breast cancer Cells.
    Wang M; Li X; Xie W; Zhong L; Leng Y; Chen X; Yang M; Qi L; Zhang Z; Liu L; Tang D
    Cancer Biother Radiopharm; 2022 Oct; 37(8):720-728. PubMed ID: 34388026
    [No Abstract]    [Full Text] [Related]  

  • 15. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
    Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
    Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1.
    André F; Ciruelos EM; Juric D; Loibl S; Campone M; Mayer IA; Rubovszky G; Yamashita T; Kaufman B; Lu YS; Inoue K; Pápai Z; Takahashi M; Ghaznawi F; Mills D; Kaper M; Miller M; Conte PF; Iwata H; Rugo HS
    Ann Oncol; 2021 Feb; 32(2):208-217. PubMed ID: 33246021
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Associations of Common Genetic Susceptibility Variants with breast cancer in Jordanian Arabs: A Case-Control Study.
    Al-Eitan LN; M Rababa'h D; Aman HA
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):3045-3054. PubMed ID: 33112566
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. machine learning to predict the cancer-specific mortality of patients with primary non-metastatic invasive breast cancer.
    Zhou CM; Xue Q; Wang Y; Tong J; Ji M; Yang JJ
    Surg Today; 2021 May; 51(5):756-763. PubMed ID: 33104877
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. 3.0 T Magnetic Resonance Functional Imaging Quantitative Parameters for Differential Diagnosis of Benign and Malignant Lesions of the breast.
    Cheng X; Chen C; Xia H; Zhang L; Xu M
    Cancer Biother Radiopharm; 2021 Aug; 36(6):448-455. PubMed ID: 32716710
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 3.